(Q43075907)

13 November 2017

Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration (English)

1 reference

13 November 2017

1

1 reference

13 November 2017

9

Alan W Partin

1 reference

13 November 2017

Lori J Sokoll

2

1 reference

13 November 2017

Dennis L Broyles

3

1 reference

13 November 2017

Chris H Bangma

4

1 reference

13 November 2017

Ron H N van Schaik

5

1 reference

13 November 2017

George G Klee

6

1 reference

13 November 2017

John T Wei

7

1 reference

13 November 2017

Martin G Sanda

8

1 reference

13 November 2017

Kevin M Slawin

10

1 reference

13 November 2017

Leonard S Marks

11

1 reference

13 November 2017

Isaac A Mizrahi

12

1 reference

13 November 2017

Sanghyuk S Shin

13

1 reference

13 November 2017

Amabelle B Cruz

14

1 reference

13 November 2017

Daniel W Chan

15

1 reference

13 November 2017

William L Roberts

16

1 reference

13 November 2017

William J Catalona

17

1 reference

13 November 2017

language of work or name

English

0 references

publication date

30 November 2012

1 reference

13 November 2017

1 reference

13 November 2017

189

1 reference

13 November 2017

5

1 reference

13 November 2017

1702-1706

1 reference

Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4273580

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4273580

Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4273580

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4273580

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4273580

Screening for prostate cancer--the controversy that refuses to die.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4273580

Clinical impact of new prostate-specific antigen WHO standardization on biopsy rates and cancer detection

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4273580

Prostate specific antigen assay standardization bias could affect clinical decision making.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4273580

Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4273580

Lowering PSA cutoffs to enhance detection of curable prostate cancer

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23206426

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassay

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23206426

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of 6 Automated Assays for Total and Free Prostate-Specific Antigen with Special Reference to Their Reactivity toward the WHO 96/670 Reference Preparation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23206426

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JURO.2012.11.149

1 reference

13 November 2017

1 reference

13 November 2017

PubMed publication ID

23206426

1 reference